Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Immunocore Holdings Plc ADR (IMCR)

Immunocore Holdings Plc ADR (IMCR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Immunocore Holdings Plc ADR 92 PARK DRIVE MILTON PARK ABINGDON OXFORDSHIRE X0 OX14 4RY GBR

www.immunocore.com Employees: 493 P: 44-12-3543-8600

Sector:

Medical

Description:

Immunocore Holdings plc is a late-stage biotechnology company. It engages in development of a novel class of T cell receptor bispecific immunotherapies designed to treat diseases, including cancer, infectious and autoimmune disease. Immunocore Holdings plc is based in Abingdon, the United Kingdom.

Key Statistics

Overview:

Market Capitalization, $K 1,684,165
Enterprise Value, $K 1,619,445
Shares Outstanding, K 50,530
Float, K 45,275
% Float 89.60%
Short Interest, K 9,520
Short Float 18.84%
Days to Cover 36.58
Short Volume Ratio 0.83
% of Insider Shareholders 10.40%
% of Institutional Shareholders 84.50%

Financials:

Annual Sales, $ 310,200 K
Annual Net Income, $ -51,090 K
Last Quarter Sales, $ 103,690 K
Last Quarter Net Income, $ -180 K
EBIT, $ -45,120 K
EBITDA, $ -40,920 K

Growth:

1-Year Return 17.63%
3-Year Return -41.85%
5-Year Return 0.00%
5-Year Revenue Growth 846.31%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.00 on 11/06/25
Next Earnings Date 02/25/26
Earnings Per Share ttm -0.57
EPS Growth vs. Prev Qtr 100.00%
EPS Growth vs. Prev Year -100.00%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

IMCR Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -7.67%
Return-on-Assets % -2.77%
Profit Margin % -16.47%
Debt/Equity 0.99
Price/Sales 4.66
Price/Cash Flow N/A
Price/Book 4.24
Book Value/Share 7.86
Interest Coverage -1.81
60-Month Beta 0.78
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar